rs587783683
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_003482.4(KMT2D):c.11386delC(p.Gln3796ArgfsTer34) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000694 in 1,441,184 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_003482.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.94e-7 AC: 1AN: 1441184Hom.: 0 Cov.: 45 AF XY: 0.00000140 AC XY: 1AN XY: 714758
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Kabuki syndrome 1 Pathogenic:1
- -
Kabuki syndrome Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in KMT2D are known to be pathogenic (PMID: 22126750). This variant has not been reported in the literature in individuals with KMT2D-related conditions. ClinVar contains an entry for this variant (Variation ID: 158717). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gln3796Argfs*34) in the KMT2D gene. It is expected to result in an absent or disrupted protein product. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at